Insulin Delivery Devices Market to amass substantial growth by 2025

October 22, 2019


According to the new research report available at MarketStudyReport.com under the title ‘Global (United States, European Union and China) Insulin Delivery Devices Market Research Report 2019-2025’, the worldwide insulin delivery devices market is presumed to grow substantially by the year 2025.
 

Insulin delivery devices are used for administering insulin for the treatment of diabetes and include apparatus such as pumps, pens, syringes and others. Cost of insulin pens and syringes is less, which allow users to choose them as their first-choice devices. However, high price of insulin jet injectors and insulin pumps poses a challenge to the market growth. Insulin jet injectors and pumps also need special maintenance and care, which increases the cost for patients.
 

Rising prevalence of diabetes and obesity globally remains the main driver for boosting insulin delivery devices market growth. Technological advancement of these devices, along with growing patient awareness about diabetes care are anticipated to hold a positive impact on the industry growth. Furthermore, easy and extensive availability of numerous insulin delivery devices will propel the market growth.
 

Details regarding the sales graph, revenue shares, production & consumption patterns, and industry trends for each segment and manufacturer are encompassed in the report. It also offers a comprehensive insight about the value chain and sales channel, alongside the mergers and acquisition undertaken by market players for expansion.
 

Insulin delivery devices market is examined on the basis of type, application spectrum and geographical outlook. Considering the type, the market is fragmented as insulin syringes, insulin pumps, insulin pens, and others, wherein, insulin pens (reusable and disposable) segment dominated the market in 2017 and is presumed to continue this trend over the analysis period. 
 

Based on the application spectrum, the market is segmented as clinics & hospitals and homecare/patients. As per the report, insulin delivery devices market from patients/homecare application is expected to witness significant growth over the forecast timeframe.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/2184692/
 

Speaking of the geographical outlook, the global insulin delivery devices market is divided into four main regions which are China, United States, European Union and rest of the world which includes Southeast Asia, Korea, Japan and India. Moreover, North America led the global market in 2017, owing to increasing instance of diabetes, FDA favoring availability of devices, and easy medical reimbursement policies in the region.
 

The prominent companies operating in insulin delivery devices market include Cellnovo, Novo Nordisk, Beta Bionics, Sanofi, Animas, Eli Lilly, BD, Medtronic, Ypsomed, Copernicus, West Pharma, Dance Biopharm, Valeritas, Debiotech, Tandem Diabetes Care, Insulet, SOOIL, MannKind, Roche, and Owen Mumford.


Frequently Asked Questions (FAQ) :

Based on the application spectrum, the market is segmented as clinics & hospitals and homecare/patients. Insulin delivery devices market from patients/homecare application is expected to witness significant growth over the forecast timeframe, claims a reliable study.
Rising prevalence of diabetes and obesity globally remains the main driver for boosting insulin delivery devices market growth. Technological advancement of these devices, along with growing patient awareness about diabetes care are anticipated to hold a positive impact on the industry growth. Furthermore, easy and extensive availability of numerous insulin delivery devices will propel the market growth.
Insulin is basically delivered through insulin delivery devices that are used for administering the hormone to the human body for the treatment of diabetes. These devices include apparatus such as pumps, pens, syringes and others. Cost of insulin pens and syringes is less, which allow users to choose them as their first-choice devices.
Speaking of the geographical outlook, the global insulin delivery devices market is divided into four main regions which are China, United States, European Union and rest of the world which includes Southeast Asia, Korea, Japan and India. Moreover, North America led the global market in 2017, owing to increasing instance of diabetes, FDA favoring availability of devices, and easy medical reimbursement policies in the region.